Friday, 29 March 2024


TOT Biopharm starts $100 mn cancer drug plant

04 December 2012 | News | By BioSpectrum Bureau

China's TOT Biopharm inaugurates anti-cancer drug plant

TOT Biopharm, China, constructs first stage of its $100 mn factory in 18 months to develop anti-cancer drugs

TOT Biopharm, China, constructs first stage of its $100 mn factory in 18 months to develop anti-cancer drugs

Singapore: China's TOT Biopharm has completed 18-month project constructing the first stage of its $100 million factory complex in eastern China's Suzhou Industrial Park. The high-tech factory complex specializes in the R&D, production and marketing of anti-cancer drugs globally.

Business leaders including Wang Shaobang, deputy director of the Taiwan Affairs Office of Jiangsu Province; Yang Zhiping, director of Suzhou Industrial Park; Qianfu, chairman of Cathay United Bank's Culture and Charity Foundation; and Gao Konglian, deputy chairman of Straits Exchange Foundation attended the inauguration ceremony.

TOT Biopharm's new factory complex meets the demand for developing the bio-pharmaceutical sector set forth in China's 12th Five-Year Development Planning for Strategic Emerging Industries. The company has leveraged the rapid growth of bio-pharmaceutical technologies in China to accelerate the building of a complete bio-pharmaceutical industry chain. The company's core products include liposomal technology-based specialty medicines, biologics and innovative drugs.

The first stage of TOT Biopharm's new factory complex includes an oral anti-cancer drug plant with separate production facilities for both cytotoxics and non-cytotoxics, an injected anti-cancer drug plant and a GMP bio pilot plant with a capacity of 500 liter for cell culture, purification and filling. TOT Biopharm is set to initiate the second stage construction to expand its production scale and improve its international competitiveness.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account